BiotechTube
Home/Homology Medicines/Albert Seymour, Ph.D.
AS

Albert Seymour, Ph.D.

President and Chief Scientific Officer

Homology Medicines

Therapeutic Areas

Rare Genetic DiseasesMetabolic DisordersNeurological Disorders

Homology Medicines Pipeline

DrugIndicationPhase
HMI-102Phenylketonuria (PKU) in adultsPhase 1/2
HMI-103Phenylketonuria (PKU) in pediatric patientsPhase 1
HMI-104 / HMI-105Metachromatic Leukodystrophy (MLD)Preclinical
HMI-106Hunter Syndrome (MPS II)Preclinical

Leadership Team at Homology Medicines

AT
Arthur Tzianabos, Ph.D.
President and Chief Executive Officer
WB
W. Bradford Smith
Chief Financial and Operating Officer
JJ
Julie Jordan, M.D.
Chief Medical Officer
TP
Timothy P. Coughlin
Board Member (Atlas Venture)
View full Homology Medicines profile